Literature DB >> 29604477

Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein.

Xiaohui Bi1, Shuping Tong2.   

Abstract

Hepatitis B virus (HBV) expresses three co-terminal envelope proteins: large (L), middle (M), and small (S), with the S protein driving the secretion of both virions and subviral particles. Virion secretion requires N-linked glycosylation at N146 in the S domain but can be impaired by immune escape mutations. An M133T mutation creating a novel glycosylation site at N131could rescue virion secretion of N146Q mutant (loss of original glycosylation site) and immune escape mutants such as G145R. Here we demonstrate that other novel N-linked glycosylation sites could rescue virion secretion of the G145R and N146Q mutants to variable extents. Both G145R and N146Q mutations impaired virion secretion through the S protein. The M133T mutation restored virion secretion through the S protein, and could work in trans. Impaired virion secretion was not necessarily associated with a similar block in the secretion of subviral particles.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis B surface antigen; Hepatitis B virus; Immune escape mutant; N-linked glycosylation; Subviral particle; Vaccine escape; Virion secretion

Mesh:

Substances:

Year:  2018        PMID: 29604477      PMCID: PMC6086723          DOI: 10.1016/j.virol.2018.03.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape.

Authors:  De-Min Yu; Xin-Hua Li; Vannary Mom; Zhong-Hua Lu; Xiang-Wei Liao; Yue Han; Christian Pichoud; Qi-Ming Gong; Dong-Hua Zhang; Yan Zhang; Paul Deny; Fabien Zoulim; Xin-Xin Zhang
Journal:  J Hepatol       Date:  2013-11-13       Impact factor: 25.083

2.  Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.

Authors:  Tao Bian; Hongxia Yan; Liping Shen; Feng Wang; Shuang Zhang; Yanqiang Cao; Shuo Zhang; Yong Zhang; Shengli Bi
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

3.  Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking.

Authors:  Romuald Patient; Christophe Hourioux; Pierre-Yves Sizaret; Sylvie Trassard; Camille Sureau; Philippe Roingeard
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

4.  Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.

Authors:  N A Terrault; S Zhou; R W McCory; T L Pruett; J R Lake; J P Roberts; N L Ascher; T L Wright
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

5.  Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

Authors:  Damien Jeantet; Isabelle Chemin; Bernard Mandrand; Albert Tran; Fabien Zoulim; Philippe Merle; Christian Trepo; Alan Kay
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

6.  Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin.

Authors:  Carsten Lambert; Tatjana Döring; Reinhild Prange
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

Review 7.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

8.  Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.

Authors:  H-Y Hsu; M-H Chang; Y-H Ni; H-L Chen
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

9.  Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.

Authors:  H L Zaaijer; P Torres; A Ontañón; L González Ponte; M H G M Koppelman; P N Lelie; F J van Hemert; H J Boot
Journal:  J Med Virol       Date:  2008-08       Impact factor: 2.327

10.  Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.

Authors:  Jisu Li; Li Zong; Camille Sureau; Luke Barker; Jack R Wands; Shuping Tong
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

View more
  9 in total

1.  A putative amphipathic alpha helix in hepatitis B virus small envelope protein plays a critical role in the morphogenesis of subviral particles.

Authors:  Sisi Yang; Zhongliang Shen; Yaoyue Kang; Liren Sun; Usha Viswanathan; Hongying Guo; Tianlun Zhou; Xinghong Dai; Jinhong Chang; Jiming Zhang; Ju-Tao Guo
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

2.  SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.

Authors:  Yue Liu; Hong Wang; Jun Zhang; Jing Yang; Lu Bai; Baisong Zheng; Tianhang Zheng; Yingchao Wang; Jianhua Li; Wenyan Zhang
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

3.  Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains.

Authors:  Lu Zhang; Le Chang; Syria Laperche; Huimin Ji; Junpeng Zhao; Xinyi Jiang; Lunan Wang; Daniel Candotti
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

4.  A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro.

Authors:  Romina Salpini; Lorenzo Piermatteo; Arianna Battisti; Luna Colagrossi; Marianna Aragri; Katia Yu La Rosa; Ada Bertoli; Patrizia Saccomandi; Miriam Lichtner; Massimo Marignani; Sarah Maylin; Constance Delaugerre; Filomena Morisco; Nicola Coppola; Aldo Marrone; Nerio Iapadre; Carlotta Cerva; Stefano Aquaro; Mario Angelico; Loredana Sarmati; Massimo Andreoni; Jens Verheyen; Francesca Ceccherini-Silberstein; Massimo Levrero; Carlo Federico Perno; Laura Belloni; Valentina Svicher
Journal:  Viruses       Date:  2020-02-23       Impact factor: 5.048

5.  Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.

Authors:  Laurissa Ouaguia; Tania Dufeu-Duchesne; Vincent Leroy; Thomas Decaens; Jean-Baptiste Reiser; Eleonora Sosa Cuevas; David Durantel; Jenny Valladeau-Guilemond; Nathalie Bendriss-Vermare; Laurence Chaperot; Caroline Aspord
Journal:  Clin Transl Immunology       Date:  2020-12-08

6.  Glycosylation of ALV-J Envelope Protein at Sites 17 and 193 Is Pivotal in the Virus Infection.

Authors:  Moru Xu; Kun Qian; Hongxia Shao; Yongxiu Yao; Venugopal Nair; Jianqiang Ye; Aijian Qin
Journal:  J Virol       Date:  2021-12-08       Impact factor: 5.103

Review 7.  Post-translational Modification Control of HBV Biological Processes.

Authors:  Fan Yang
Journal:  Front Microbiol       Date:  2018-11-01       Impact factor: 5.640

8.  Hepatitis B Virus Exploits ERGIC-53 in Conjunction with COPII to Exit Cells.

Authors:  Lisa Zeyen; Tatjana Döring; Reinhild Prange
Journal:  Cells       Date:  2020-08-12       Impact factor: 6.600

9.  Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.

Authors:  Mary C Kuhns; Vera Holzmayer; Mark Anderson; Anne L McNamara; Silvia Sauleda; Dora Mbanya; Pham T Duong; Nguyen T T Dung; Gavin A Cloherty
Journal:  Viruses       Date:  2021-10-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.